We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHO icon
1401
Invesco Water Resources ETF
PHO
$1.98B
$75K ﹤0.01%
2,830
+800
+39% +$20.9K
SMFG icon
1402
Sumitomo Mitsui Financial
SMFG
$167B
$75K ﹤0.01%
8,719
– –
ZTS icon
1403
Zoetis
ZTS
$32.2B
$75K ﹤0.01%
2,623
– –
OCLR
1404
DELISTED
Oclaro Inc.
OCLR
$75K ﹤0.01%
24,279
-61,199
-72% -$171K
LAYN
1405
DELISTED
Layne Christensen Co
LAYN
$75K ﹤0.01%
4,144
– –
SGYP
1406
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$74K ﹤0.01%
+14,000
New +$78.5K
SLXP
1407
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$74K ﹤0.01%
+729
New +$74.6K
GT.PRA
1408
DELISTED
GOODYEAR TIRE & RUBR CO PFD CONV (OH)
GT.PRA
$74K ﹤0.01%
1,025
– –
DTE icon
1409
DTE Energy
DTE
$30.6B
$73K ﹤0.01%
1,181
-3,701
-76% -$218K
HL icon
1410
Hecla Mining
HL
$10.2B
$73K ﹤0.01%
24,235
+3,000
+14% +$9.85K
UNF icon
1411
Unifirst Corp
UNF
$5.38B
$73K ﹤0.01%
668
-272
-29% -$29.5K
EEFT icon
1412
Euronet Worldwide
EEFT
$3.01B
$72K ﹤0.01%
1,739
-78
-4% -$3.23K
APU
1413
DELISTED
AmeriGas Partners, L.P.
APU
$72K ﹤0.01%
1,730
– –
ADT
1414
DELISTED
ADT Corp
ADT
$72K ﹤0.01%
2,433
-425
-15% -$14K
CRH icon
1415
CRH
CRH
$68.7B
$70K ﹤0.01%
2,500
– –
PVH icon
1416
PVH
PVH
$3.87B
$70K ﹤0.01%
562
-500
-47% -$61.6K
SAN icon
1417
Banco Santander
SAN
$200B
$70K ﹤0.01%
8,081
– –
VTV icon
1418
Vanguard Value ETF
VTV
$189B
$70K ﹤0.01%
907
-2,848
-76% -$216K
PCYC
1419
DELISTED
PHARMACYCLICS INC
PCYC
$70K ﹤0.01%
700
-175
-20% -$22.7K
LR
1420
DELISTED
LAFARGE ADS (1/4 COM) NEW
LR
$70K ﹤0.01%
3,600
– –
ACGL icon
1421
Arch Capital
ACGL
$36.3B
$69K ﹤0.01%
3,600
– –
DHI icon
1422
D.R. Horton
DHI
$41.3B
$69K ﹤0.01%
3,296
-1,650
-33% -$37.3K
TEG
1423
DELISTED
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
$69K ﹤0.01%
1,174
-287
-20% -$15.9K
IRC
1424
DELISTED
INLAND REAL ESTATE CORP
IRC
$69K ﹤0.01%
6,589
– –
ACIW icon
1425
ACI Worldwide
ACIW
$5.88B
$68K ﹤0.01%
3,519
– –
55 56
57
58 59

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.